Merck | MRK - Operating Profit


Merck reported EUR1.05B in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Adidas EUR 574M 131M Jun/2026
Adyen EUR 627.12M 144.33M Dec/2025
Akzo Nobel EUR 251M 3M Jun/2026
Alcon AG USD 297M 16M Mar/2026
Amadeus IT EUR 478.3M 12.8M Jun/2026
Amarin USD -2.26M 564K Dec/2025
AstraZeneca USD 3.16B 3.95B Jun/2026
BASF EUR 1.43B 31M Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Danone EUR 1.86B 6M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 268M 395M Mar/2026
Genmab DKK 260M 199M Dec/2025
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Henkel EUR 1.64B 220M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Infineon EUR 606M 120M Jun/2026
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Linde USD 2.38B 129M Mar/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
UCB EUR 1.29B 571M Dec/2025